Beside these similarities between AD and LSD, several studies of AD postmortem brains indicate that the sphingolipid metabolism is altered during AD progression, further substantiated by biochemical studies, linking sphingolipids to APP processing [125–131] (Figure 2). The gene discussed is APP; the disease is Alzheimer disease.